Lanean...
Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder
BACKGROUND: This open trial was conducted to evaluate the effectiveness of intravenous clomipramine (CMI) in refractory obsessive-compulsive disorder (OCD). METHODS: Thirty OCD poor responders to previous multiple trials of anti-obsessive medications were selected and admitted to the hospital. Sever...
Gorde:
| Argitaratua izan da: | Int J Neuropsychopharmacol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772819/ https://ncbi.nlm.nih.gov/pubmed/26221004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyv084 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|